By LESLIE PICKERNOV. 2, 2015
Early Monday morning, AmSurg Corporation gave TeamHealth Holdings an ultimatum: Accept our $7.6 billion takeover proposal by 4 p.m. on Tuesday or we withdraw.About 24 hours ahead of the deadline, AmSurg retracted its cash-and-stock offer after TeamHealth said the new bid still undervalued the company.The now-abandoned deal would have combined AmSurg, which operates outpatient surgery centers, with TeamHealth, a provider of physician outsourcing services.The two sides met more than a month ago to discuss a cash-and-stock deal, whose price was bumped up by $4 per share in cash on Monday. AmSurg and TeamHealth would have owned 50 percent each of the combined company.AdvertisementBut for TeamHealth, the revised bid was still not good enough, leading the company to reject TeamHealth’s offer publicly on Monday.Please verify you're not a robot by clicking the box.Invalid email address. Please re-enter.You must select a newsletter to subscribe to.View all New York Times newsletters.The episode underscores the need by many in the health care industry to consolidate in order to remain competitive. TeamHealth recently scooped up IPC Healthcare for $1.6 billion and is focused on integrating the short-term care provider into its business. AmSurg acquired Sheridan Healthcare, another physician outsourcing service, in July for $2.3 billion.AdvertisementThe additional $4 a share that AmSurg offered Monday was to compensate for any potential penalties in financing the IPC deal, according to a statement.“It is difficult to see how any reasonable stand-alone financial forecast could equal or surpass the value creation to your shareholders provided by this proposal,” Christopher Holden, president and chief executive of AmSurg, said in a letter to TeamHealth that was published Monday, before the offer was rejected.Mr. Holden also noted in the letter that if the company were to engage with AmSurg in the future, it would be as part of an sale process with multiple parties involved.We’re interested in your feedback on this page. Tell us what you think.